Sandvold; Marit Liland
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sandvold; Marit Liland.The latest application filed is for "anti-human equilibrative nucleoside transporter 1 (hent1) antibodies adn methods of use thereof".
- Sandvold; Marit Liland - Porsgrunn N/A NO
- Sandvold; Marit Liland - Oslo NO
| Patent | Date |
|---|---|
| Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents Grant 9,428,540 - Myhren , et al. August 30, 2 | 2016-08-30 |
| ANTI-HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (hENT1) ANTIBODIES ADN METHODS OF USE THEREOF App 20140249298 - Sandvold; Marit Liland ; et al. | 2014-09-04 |
| Azacytidine analogues and uses thereof Grant 8,399,420 - Silverman , et al. March 19, 2 | 2013-03-19 |
| Dioxolane derivates for the treatment of cancer Grant 8,349,834 - Myhren , et al. January 8, 2 | 2013-01-08 |
| Methods and Compositions for Treating or Ameliorating Cancer Using Gemcitabine-5'-Elaidate App 20130005678 - Sandvold; Marit Liland ; et al. | 2013-01-03 |
| Systems and Methods for Detecting hENT1 Expression in Hematological Disorders App 20120264710 - Sandvold; Marit Liland ; et al. | 2012-10-18 |
| Fatty Acid Esters Of Glucocorticoids As Anti-inflammatory And Anti-cancer Agents App 20100099654 - Finn; Myhren ; et al. | 2010-04-22 |
| Dioxolane Derivates For The Treatment Of Cancer App 20100062996 - Myhren; Finn ; et al. | 2010-03-11 |
| Azacytidine Analogues And Uses Thereof App 20090209477 - Silverman; Lewis ; et al. | 2009-08-20 |
| Oral Dosage Forms of Gemcitabine Derivatives App 20080280851 - Myhren; Finn ; et al. | 2008-11-13 |
| Oral dosage forms of gemcitabine derivatives App 20070225248 - Myhren; Finn ; et al. | 2007-09-27 |
| Chemical compounds App 20070135436 - Myhren; Finn ; et al. | 2007-06-14 |
| Fatty acid derivatives Grant 6,762,175 - Myhren , et al. July 13, 2 | 2004-07-13 |
| Methods of treating disorders using lipophilic derivatives App 20040063677 - Myhren, Finn ; et al. | 2004-04-01 |
| Fatty acid derivatives App 20030153544 - Myhren, Finn ; et al. | 2003-08-14 |
| Gemcitabine derivatives Grant 6,384,019 - Myhren , et al. May 7, 2 | 2002-05-07 |
| Gemcitabine Derivatives App 20020042391 - MYHREN, FINN ; et al. | 2002-04-11 |
| Fatty Acid Derivatives App 20010006962 - MYHREN, FINN ; et al. | 2001-07-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 